Some properties of prostaglandin E1 action on muscle.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D003650:Decamethonium Compounds / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D001337:Autonomic Agents; D003650:Decamethonium Compounds; D011453:Prostaglandins; D014667:Vasopressins; D000804:Angiotensin II; D012701:Serotonin; D010121:Oxytocin; D001285:Atropine; D006632:Histamine; D012110:Reserpine; D004155:Diphenhydramine; D008238:Lysergic Acid Diethylamide; D010830:Physostigmine; D011433:Propranolol; D000109:Acetylcholine; D001920:Bradykinin; D014403:Tubocurarine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine